Page last updated: 2024-11-05

triazolam and Tinnitus

triazolam has been researched along with Tinnitus in 1 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Tinnitus: A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greenblatt, DJ1
Shader, RI1
Divoll, M1
Harmatz, JS1

Trials

1 trial available for triazolam and Tinnitus

ArticleYear
Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:5

    Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; D

1984